// App-Quantinova.ai

1015 : Repurposing the FDA-approved drug carbidopa to treat human cancers

Researchers

Presenter

  • Vadivel Ganapathy

Principal Investigators

  • Ellappan Babu

  • Sabarish Ramachandran

  • Yangzom D. Bhutia

Medical Centers

  • Texas Tech University Health Sciences, Lubbock, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Parkinson's disease

  • Pancreatic cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • Norepinephrine bitartrate

  • Carbidopa

  • Dopamine hydrochloride

  • AS-400

  • Levodopa

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved